nivolumab,ipilimumab
bms
['nivo']
#esmo2022 still another adjuvant io negative trial (here nivo+ipi 6 months vs placebo)... the story seems to be the same than tki in adjuvant setting : 1 positive, 3 negative, some minor differences between trials... #cancer 
urologue à L'institut Paoli-Calmettes à Marseille